Other Technologies. Subject to the provisions of this Section 12.7 and Section 7.2, Tularik shall have the exclusive right to develop, make and commercialize therapeutic products incorporating agents that are directed against Targets but are not [ * ]. For the first [ * ] of the Research Term, Roche Bioscience shall have the exclusive right to enter into an agreement with Tularik to develop [ * ]. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Tularik Inc), Research Collaboration and License Agreement (Tularik Inc), Research Collaboration and License Agreement (Tularik Inc)